Methods using desmopressin acetate in orodispersible form

US9220747B2 · kind B2 · utility

Assignee

• Ferring B.V. · NL

Inventors

• Anders Nilsson · Västerås, SE
• Hans Lindner · Leichlingen, DE
• Jçrgen Wittendorff · Copenhagen, DK

Key dates

• Filing date: Jul 9, 2014
• Grant date: Dec 29, 2015
• Expiry date: Jul 9, 2034

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K9/2095
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Described are orodispersible solid dosage forms of desmopressin or a pharmaceutically acceptable salt thereof useful for treating diseases or conditions such as incontinence, primary nocturnal enuresis (PNE), nocturia, and central diabetes insipidus. The dosage forms disintegrate in the mouth within 10 seconds and provide good desmopressin bioavailability.